Use of anti-inflammatory agents in destructive corneal disease.
The use of anti-inflammatory agents is important in the treatment of destructive corneal disease. The basic principles of the action of corticosteroids and prostaglandin inhibitors, and the application of these agents to various experimental and clinical situations, are presented. The corticosteroids are the most effective of all the anti-inflammatory agents but have many unfortunate side-effects. The prostaglandin inhibitors and other agents have fewer side-effects, but are less effective.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000921:Antibody-Producing Cells / Q000187:drug effects; D003316:Corneal Diseases / Q000188:drug therapy*; D016039:Corneal Transplantation; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007634:Keratitis / Q000188:drug therapy; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011817:Rabbits; D014184:Transplantation, Homologous
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D011448:Prostaglandin Antagonists